COVID-19与风湿肌肉骨骼疾病患者:爱尔兰人群的感染率、态度及用药依从性
该研究通过在线调查1381名爱尔兰风湿肌肉骨骼疾病(RMD)患者,发现COVID-19症状报告率为3.7%,阳性检测率为0.46%,与一般人群一致。使用免疫抑制药物的患者症状频率较低(OR 0.48),且用药依从性较高者更倾向于参考卫生当局指南(89.3% vs 79.9%,P<0.001)。多数受访者支持虚拟门诊(70.4%)。
要点
- RMD患者COVID-19阳性率与一般人群相似(0.46%),症状报告率3.7%。
- 使用免疫抑制药物与较低COVID-19症状风险相关(OR 0.48,95%CI 0.27-0.88)。
- 遵循卫生当局指南者用药依从性更高(89.3% vs 79.9%,P<0.001)。
核心结论
- RMD患者COVID-19阳性率与一般爱尔兰人群相似。
- 使用免疫抑制药物及遵循指南者COVID-19症状频率较低。
- 受访者支持卫生当局建议及虚拟门诊。
研究设计与样本
- 在线调查通过Arthritis Ireland网站和社交媒体发放,共1381名RMD患者受访,74.8%使用免疫抑制药物。
主要发现
- COVID-19症状报告率为3.7%,阳性检测率为0.46%。
- 脊柱关节炎患者症状频率更高(OR 2.06,95%CI 1.14-3.70)。
- 使用免疫抑制药物者症状频率更低(OR 0.48,95%CI 0.27-0.88)。
- 遵循HSE指南者症状频率更低(OR 0.47,95%CI 0.25-0.89)。
- 用药依从率为84.1%,57.1%使用卫生当局指南获取用药信息。
关键数值与推荐
- 依从用药者中参考指南者比例更高(89.3% vs 79.9%,P<0.001)。
- 有COVID-19症状者用药依从率更低(64.0% vs 85.1%,P=0.009)。
- 70.4%受访者支持使用虚拟门诊。
临床怎么用
- 应鼓励RMD患者遵循卫生当局指南以提升用药依从性。
- 虚拟门诊在RMD患者中接受度较高,可考虑推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To establish, amongst Irish rheumatic musculoskeletal disease (RMD) patients, rates of COVID-19 symptoms and positive tests, DMARD adherence and attitudes to virtual clinics. METHODS: An online survey assessing COVID-19 status, RMD diagnoses, adherence and information sources was disseminated via the Arthritis Ireland website and social media channels. RESULTS: There were 1381 respondents with 74.8% on immunosuppressive medication. Symptoms of COVID-19 were reported by 3.7% of respondents of which 0.46% tested positive, consistent with the general Irish population. The frequency of COVID-19 symptoms was higher for respondents with spondyloarthropathy [odds ratio (OR) 2.06, 95% CI: 1.14, 3.70] and lower in those on immunosuppressive medication (OR 0.48, 95% CI: 0.27, 0.88), and those compliant with health authority (HSE) guidance (OR 0.47, 95% CI: 0.25, 0.89). Adherence to RMD medications was reported in 84.1%, with 57.1% using health authority guidelines for information on medication use. Importantly, adherence rates were higher amongst those who cited guidelines (89.3% vs 79.9%, P <0.001), and conversely lower in those with COVID-19 symptoms (64.0% vs 85.1%, P =0.009). Finally, the use of virtual clinics was supported by 70.4% of respondents. CONCLUSION: The rate of COVID-19 positivity in RMD patients was similar to the general population. COVID-19 symptoms were lower amongst respondents on immunosuppressive medication and those adherent to medication guidelines. Respondents were supportive of HSE advice and virtual clinics.
引用
- Murray K, Quinn S, Turk M, et al. COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology (Oxford). 2021. PMID: 33164088. doi:10.1093/rheumatology/keaa694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。